HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of temporal arteritis with ocular involvement.

Abstract
A 78-year-old white woman had catastrophic visual loss in one eye due to temporal arteritis. Despite treatment with doses of oral corticosteroids high enough to normalize the Westergren erythrocyte sedimentation rate, she experienced progressive retinal ischemia with visual loss in the second eye. The use of 1,000 mg of pulsed intravenous methylprednisolone every 12 hours restored her vision. Brief hospitalization of patients with arteritic ischemic optic neuropathy for treatment with intravenous methylprednisolone may offer a significant chance of visual recovery of the involved eye and provide optimal protection to the uninvolved eye.
AuthorsS I Rosenfeld, G S Kosmorsky, T G Klingele, R M Burde, E M Cohn
JournalThe American journal of medicine (Am J Med) Vol. 80 Issue 1 Pg. 143-5 (Jan 1986) ISSN: 0002-9343 [Print] United States
PMID3942148 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Methylprednisolone
Topics
  • Aged
  • Blindness (etiology)
  • Female
  • Giant Cell Arteritis (complications, drug therapy)
  • Humans
  • Methylprednisolone (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: